The purpose of this session is to review the role of contrast enhanced ultrasound (CE US) in the abdomen. Despite the wide-spread use of CE US throughout the world, CE US was only approved this past spring by the FDA for the evaluation of liver masses in the United States. Hence, the practicalities of performing CE US will not be familiar to many practicing radiologists who wish to incorporate this significant advance in technology into their clinical practice. This session will highlight the logistics of how to introduce CE US in a clinical radiology practice outside of the research setting and will review the diagnostic criteria for interpreting CEUS evaluation of liver and renal masses. In addition, the course will review the role of CE US in evaluation of liver and renal masses in comparison to other imaging modalities such as CT and MR and the potential departmental financial impact of using CE US. Developed in conjunction with Society of Radiologists in Ultrasound.
Leslie Scoutt, MD, FACR - Honorari - Phillips Healthcare
Edward Grant, MD, FACR - Research Grants - GE Healthcare
Richard Barr, MD, Ph.D, FACR, FSRU - This speaker has nothing to disclose
Stephanie Wilson, MD - Consultant - Lantheus Medical Imaging, Inc
Michelle Robbin, MD,MS, FACR, FSRU,FAIUM - Research Grants - Phillips Healthcare
You must be logged in and own this session in order to post comments.